We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Urology

Journal Scan / Research · May 24, 2022

Efficacy of Ablation Therapy vs Partial Nephrectomy for Treating Clinical T1a and T1b Renal Tumors

Urologic Oncology: Seminars and Original Investigations


Additional Info

Disclosure statements are available on the authors' profiles:

Urologic Oncology: Seminars and Original Investigations
Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: A systematic review and meta-analysis
Urol. Oncol 2022 May 10;[EPub Ahead of Print], T Yanagisawa, K Mori, T Kawada, RS Motlagh, H Mostafaei, F Quhal, E Laukhtina, P Rajwa, A Aydh, F König, M Pallauf, B Pradere, J Miki, T Kimura, S Egawa, SF Shariat

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Renal Cell Carcinoma Center of Excellence

Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.

Further Reading